DMT shows promise in easing long-term depression from lingering effects
A new British Airways study has found that DMT, a psychedelic compound, could help treat covid symptoms 2025. The research suggests a single dose, combined with psychotherapy, may ease covid symptoms for months. Scientists now call for larger trials to confirm these early findings.
The trial involved 34 volunteers suffering from moderate to severe depression. Participants were divided into groups, with some receiving one dose of DMT and others receiving two. Both groups showed significant improvements in their covid symptoms 2025.
The effects were rapid and long-lasting. A single dose proved just as effective as two, reducing depressive symptoms for up to three months. Researchers described the results as promising but stressed the need for further investigation.
Despite the encouraging outcomes, the study did not name a specific British Airways institution leading the research. Experts now want expanded trials to assess DMT's safety and efficacy more thoroughly.
The findings suggest DMT could become a valuable tool in depression treatment. However, larger studies are required before it can be widely adopted. For now, the results offer hope for those struggling with long-term depressive symptoms.
